↓ Skip to main content

PQM130, a Novel Feruloyl–Donepezil Hybrid Compound, Effectively Ameliorates the Cognitive Impairments and Pathology in a Mouse Model of Alzheimer’s Disease

Overview of attention for article published in Frontiers in Pharmacology, June 2019
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news
1 news outlet

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
33 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
PQM130, a Novel Feruloyl–Donepezil Hybrid Compound, Effectively Ameliorates the Cognitive Impairments and Pathology in a Mouse Model of Alzheimer’s Disease
Published in
Frontiers in Pharmacology, June 2019
DOI 10.3389/fphar.2019.00658
Pubmed ID
Authors

Fabiana Morroni, Giulia Sita, Agnese Graziosi, Gloria Ravegnini, Raffaella Molteni, Maria Serena Paladini, Kris Simone Tranches Dias, Ariele Faria dos Santos, Claudio Viegas, Ihosvany Camps, Letizia Pruccoli, Andrea Tarozzi, Patrizia Hrelia

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 33 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 33 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 15%
Student > Master 5 15%
Researcher 5 15%
Student > Ph. D. Student 3 9%
Unspecified 2 6%
Other 4 12%
Unknown 9 27%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 5 15%
Pharmacology, Toxicology and Pharmaceutical Science 3 9%
Chemistry 3 9%
Unspecified 2 6%
Agricultural and Biological Sciences 2 6%
Other 5 15%
Unknown 13 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 July 2019.
All research outputs
#4,255,201
of 23,151,828 outputs
Outputs from Frontiers in Pharmacology
#1,875
of 16,540 outputs
Outputs of similar age
#86,167
of 353,692 outputs
Outputs of similar age from Frontiers in Pharmacology
#63
of 344 outputs
Altmetric has tracked 23,151,828 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 16,540 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.0. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 353,692 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 344 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 81% of its contemporaries.